Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention

DQ Huang, HB El-Serag, R Loomba - Nature reviews Gastroenterology …, 2021 - nature.com
One quarter of the global population is estimated to have nonalcoholic fatty liver disease
(NAFLD). The incidence of nonalcoholic steatohepatitis (NASH) is projected to increase by …

NAFLD‐related hepatocellular carcinoma: The growing challenge

PA Shah, R Patil, SA Harrison - Hepatology, 2023 - journals.lww.com
Hepatocellular carcinoma (HCC) is a common cause of cancer‐related mortality and
morbidity worldwide. With the obesity pandemic, NAFLD‐related HCC is contributing to the …

The hallmarks of ferroptosis

SJ Dixon, BR Stockwell - Annual review of cancer biology, 2019 - annualreviews.org
Ferroptosis is a nonapoptotic, iron-dependent form of cell death that can be activated in
cancer cells by natural stimuli and synthetic agents. Three essential hallmarks define …

Acetyl coenzyme A: a central metabolite and second messenger

F Pietrocola, L Galluzzi, JM Bravo-San Pedro, F Madeo… - Cell metabolism, 2015 - cell.com
Acetyl-coenzyme A (acetyl-CoA) is a central metabolic intermediate. The abundance of
acetyl-CoA in distinct subcellular compartments reflects the general energetic state of the …

The interplay between cell signalling and the mevalonate pathway in cancer

PJ Mullen, R Yu, J Longo, MC Archer… - Nature Reviews Cancer, 2016 - nature.com
The mevalonate (MVA) pathway is an essential metabolic pathway that uses acetyl-CoA to
produce sterols and isoprenoids that are integral to tumour growth and progression. In …

Metabolic control of YAP and TAZ by the mevalonate pathway

G Sorrentino, N Ruggeri, V Specchia… - Nature cell …, 2014 - nature.com
The YAP and TAZ mediators of the Hippo pathway (hereafter called YAP/TAZ) promote
tissue proliferation and organ growth. However, how their biological properties intersect with …

[HTML][HTML] Statin use and reduced cancer-related mortality

SF Nielsen, BG Nordestgaard… - New England Journal of …, 2012 - Mass Medical Soc
Background A reduction in the availability of cholesterol may limit the cellular proliferation
required for cancer growth and metastasis. We tested the hypothesis that statin use begun …

Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention

A Albini, G Pennesi, F Donatelli… - Journal of the …, 2010 - academic.oup.com
Due to the aging of the populations of developed countries and a common occurrence of risk
factors, it is increasingly probable that a patient may have both cancer and cardiovascular …

The mevalonate pathway, a metabolic target in cancer therapy

B Guerra, C Recio, H Aranda-Tavío… - Frontiers in …, 2021 - frontiersin.org
A hallmark of cancer cells includes a metabolic reprograming that provides energy, the
essential building blocks, and signaling required to maintain survival, rapid growth …

Statins are associated with a reduced risk of hepatocellular cancer: a systematic review and meta-analysis

S Singh, PP Singh, AG Singh, MH Murad, W Sanchez - Gastroenterology, 2013 - Elsevier
BACKGROUND & AIMS: Hepatocellular carcinoma (HCC) is a leading cause of cancer-
related mortality worldwide. Several studies have shown that statins could have …